Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Millenson

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Healthplan|June 3, 1999
Amnesia. When it comes to health care, Americans seem to have forgotten the lessons of the recent pastM Millenson
Hospitals & Health Networks|February 24, 2001
Big ideas. Wild cards: surprises? You betM Millenson
The Healthcare Forum Journal|August 5, 1998
Demanding medical excellence: a conversation with Michael Millenson. Interview by Joe FlowerM Millenson
The Joint Commission Journal on Quality Improvement|April 21, 1998
Demanding medical excellence: an interview with Michael Millenson. Interview by Louise KaegiM Millenson
Blood|January 15, 1992
A2 domain of human recombinant-derived factor VIII is required for procoagulant activity but not for thrombin cleavageD D Pittman, M Millenson, K Marquette, et al.
Leukemia & Lymphoma|October 30, 2009
Pediatric nodal marginal zone lymphoma may develop in the adult populationElena Gitelson, Tahseen Al-Saleem, Valentin Robu, et al.
Obstetrics and Gynecology|May 1, 1996
Possible association between the Norplant contraceptive system and thrombotic thrombocytopenic purpuraJ L Fraser, M Millenson, E R Malynn, et al.
The Journal of American Health Policy|February 8, 1992
America speaks. Was anyone listening?R Sorian, D Kohn, M Millenson, et al.
Blood|April 15, 1992
Monitoring "mini-intensity" anticoagulation with warfarin: comparison of the prothrombin time using a sensitive thromboplastin with prothrombin fragment F1+2 levelsM M Millenson, K A Bauer, J P Kistler, et al.
Seminars in Oncology|August 1, 1997
Paclitaxel (1-hour) and carboplatin (area under the concentration-time curve 7.5) in advanced non-small cell lung cancer: a phase II study of the Fox Chase Cancer Center and its networkC J Langer, M Millenson, E Rosvold, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Healthplan|June 3, 1999
Amnesia. When it comes to health care, Americans seem to have forgotten the lessons of the recent pastM Millenson
Hospitals & Health Networks|February 24, 2001
Big ideas. Wild cards: surprises? You betM Millenson
The Healthcare Forum Journal|August 5, 1998
Demanding medical excellence: a conversation with Michael Millenson. Interview by Joe FlowerM Millenson
The Joint Commission Journal on Quality Improvement|April 21, 1998
Demanding medical excellence: an interview with Michael Millenson. Interview by Louise KaegiM Millenson
Blood|January 15, 1992
A2 domain of human recombinant-derived factor VIII is required for procoagulant activity but not for thrombin cleavageD D Pittman, M Millenson, K Marquette, et al.
Leukemia & Lymphoma|October 30, 2009
Pediatric nodal marginal zone lymphoma may develop in the adult populationElena Gitelson, Tahseen Al-Saleem, Valentin Robu, et al.
Obstetrics and Gynecology|May 1, 1996
Possible association between the Norplant contraceptive system and thrombotic thrombocytopenic purpuraJ L Fraser, M Millenson, E R Malynn, et al.
The Journal of American Health Policy|February 8, 1992
America speaks. Was anyone listening?R Sorian, D Kohn, M Millenson, et al.
Blood|April 15, 1992
Monitoring "mini-intensity" anticoagulation with warfarin: comparison of the prothrombin time using a sensitive thromboplastin with prothrombin fragment F1+2 levelsM M Millenson, K A Bauer, J P Kistler, et al.
Seminars in Oncology|August 1, 1997
Paclitaxel (1-hour) and carboplatin (area under the concentration-time curve 7.5) in advanced non-small cell lung cancer: a phase II study of the Fox Chase Cancer Center and its networkC J Langer, M Millenson, E Rosvold, et al.
Pageof 5